mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Marginal read alignment evidence | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
| * | NC_000913_3_bme_pgi | 4,296,061 | 0 | C | T | 34.8% | 43.6 / 35.9 | 46 | intergenic (+266/+376) | gltP/yjcO | glutamate/aspartate:proton symporter/Sel1 family TPR‑like repeat protein |
| * | NC_000913_3_bme_pgi | 526,800 | 0 | A | G | 28.1% | 139.8 / 72.6 | 98 | E1180E (GAA→GAG) | rhsD | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
| * | NC_000913_3_bme_pgi | 526,792 | 0 | A | C | 27.1% | 159.8 / 64.6 | 107 | S1178R (AGC→CGC) | rhsD | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
| * | NC_000913_3_bme_pgi | 526,796 | 0 | C | G | 26.9% | 179.2 / 69.4 | 104 | A1179G (GCG→GGG) | rhsD | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
| Marginal new junction evidence (lowest skew 10 of 19 shown) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
| * | ? | NC_000913_3_bme_pgi | 781577 = | 58 (0.970) | 30 (0.510) +GAAG |
8/290 | 5.2 | 45.1% | noncoding (1/76 nt) | lysQ | tRNA‑Lys |
| ? | NC_000913_3_bme_pgi | = 2521006 | 17 (0.280) | noncoding (76/76 nt) | valU | tRNA‑Val | |||||
| * | ? | NC_000913_3_bme_pgi | = 411171 | 81 (1.350) | 5 (0.110) +36 bp |
4/226 | 5.8 | 7.0% | noncoding (94/191 nt) | REP35 (repetitive extragenic palindromic) element; contains 4 REP sequences | REP35 (repetitive extragenic palindromic) element; contains 4 REP sequences |
| ? | NC_000913_3_bme_pgi | = 411344 | 94 (1.570) | coding (1138/1185 nt) | araJ | L‑arabinose‑inducible putative transporter, MFS family | |||||
| * | ? | NC_000913_3_bme_pgi | = 2066613 | 24 (0.400) | 4 (0.070) | 4/284 | 6.9 | 14.9% | coding (709/1017 nt) | insH1 | IS5 transposase and trans‑activator |
| ? | NC_000913_3_bme_pgi | = 2102140 | NA (NA) | coding (772/1017 nt) | insH1 | IS5 transposase and trans‑activator | |||||
| * | ? | NC_000913_3_bme_pgi | = 274353 | NA (NA) | 4 (0.070) | 4/284 | 6.9 | NA | coding (765/1017 nt) | insH1 | IS5 transposase and trans‑activator |
| ? | NC_000913_3_bme_pgi | = 274402 | NA (NA) | coding (716/1017 nt) | insH1 | IS5 transposase and trans‑activator | |||||
| * | ? | NC_000913_3_bme_pgi | 1242091 = | 41 (0.680) | 5 (0.090) | 3/276 | 7.4 | 11.0% | intergenic (‑20/+75) | cvrA/ldcA | putative cation/proton antiporter/murein tetrapeptide carboxypeptidase; LD‑carboxypeptidase A |
| ? | NC_000913_3_bme_pgi | 1242139 = | 43 (0.770) | intergenic (‑68/+27) | cvrA/ldcA | putative cation/proton antiporter/murein tetrapeptide carboxypeptidase; LD‑carboxypeptidase A | |||||
| * | ? | NC_000913_3_bme_pgi | 3171760 = | 56 (0.930) | 3 (0.050) | 3/284 | 7.5 | 5.1% | coding (1277/1350 nt) | qseC | quorum sensing sensory histidine kinase in two‑component regulatory system with QseB |
| ? | NC_000913_3_bme_pgi | 3171791 = | 59 (1.030) | coding (1308/1350 nt) | qseC | quorum sensing sensory histidine kinase in two‑component regulatory system with QseB | |||||
| * | ? | NC_000913_3_bme_pgi | 2260703 = | 63 (1.050) | 3 (0.050) | 3/282 | 7.5 | 4.4% | coding (708/1692 nt) | fruA | fused fructose‑specific PTS enzymes: IIBcomponent/IIC components |
| ? | NC_000913_3_bme_pgi | 2260756 = | 70 (1.230) | coding (655/1692 nt) | fruA | fused fructose‑specific PTS enzymes: IIBcomponent/IIC components | |||||
| * | ? | NC_000913_3_bme_pgi | = 2259726 | 67 (1.120) | 3 (0.050) | 3/284 | 7.5 | 3.9% | coding (1685/1692 nt) | fruA | fused fructose‑specific PTS enzymes: IIBcomponent/IIC components |
| ? | NC_000913_3_bme_pgi | = 2259784 | 83 (1.450) | coding (1627/1692 nt) | fruA | fused fructose‑specific PTS enzymes: IIBcomponent/IIC components | |||||
| * | ? | NC_000913_3_bme_pgi | = 2066557 | 23 (0.380) | 3 (0.050) | 3/284 | 7.5 | 12.0% | coding (765/1017 nt) | insH1 | IS5 transposase and trans‑activator |
| ? | NC_000913_3_bme_pgi | = 2102196 | NA (NA) | coding (716/1017 nt) | insH1 | IS5 transposase and trans‑activator | |||||
| * | ? | NC_000913_3_bme_pgi | = 2066557 | 23 (0.380) | 3 (0.050) | 3/284 | 7.5 | 12.0% | coding (765/1017 nt) | insH1 | IS5 transposase and trans‑activator |
| ? | NC_000913_3_bme_pgi | = 2066606 | 22 (0.380) | coding (716/1017 nt) | insH1 | IS5 transposase and trans‑activator | |||||